160 related articles for article (PubMed ID: 10959901)
1. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.
Antunes NL; Khakoo Y; Matthay KK; Seeger RC; Stram DO; Gerstner E; Abrey LE; Dalmau J
J Pediatr Hematol Oncol; 2000; 22(4):315-20. PubMed ID: 10959901
[TBL] [Abstract][Full Text] [Related]
2. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
[TBL] [Abstract][Full Text] [Related]
3. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues.
Connolly AM; Pestronk A; Mehta S; Pranzatelli MR; Noetzel MJ
J Pediatr; 1997 Jun; 130(6):878-84. PubMed ID: 9202608
[TBL] [Abstract][Full Text] [Related]
4. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies.
Hayward K; Jeremy RJ; Jenkins S; Barkovich AJ; Gultekin SH; Kramer J; Crittenden M; Matthay KK
J Pediatr; 2001 Oct; 139(4):552-9. PubMed ID: 11598603
[TBL] [Abstract][Full Text] [Related]
5. Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome.
Fisher PG; Wechsler DS; Singer HS
Pediatr Neurol; 1994 Jun; 10(4):309-12. PubMed ID: 8068157
[TBL] [Abstract][Full Text] [Related]
6. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome.
Korfei M; Fühlhuber V; Schmidt-Wöll T; Kaps M; Preissner KT; Blaes F
J Neuroimmunol; 2005 Dec; 170(1-2):150-7. PubMed ID: 16203043
[TBL] [Abstract][Full Text] [Related]
7. Antineuronal antibody in a patient with neuroblastoma and opsoclonus-myoclonus-ataxia: a case report.
Salmaggi A; Nemni R; Pozzi A; Silvani A; Forno MG; Luksch R; Confalonieri P; Boiardi A
Tumori; 1997; 83(3):709-11. PubMed ID: 9267493
[TBL] [Abstract][Full Text] [Related]
8. Opsoclonus-myoclonus and antineuronal antibodies in neuroblastoma.
Blatt J
Pediatr Hematol Oncol; 1996; 13(5):iii-v. PubMed ID: 10897807
[No Abstract] [Full Text] [Related]
9. Paraneoplastic neurological antibodies: a laboratory experience.
Karim AR; Hughes RG; Winer JB; Williams AC; Bradwell AR
Ann N Y Acad Sci; 2005 Jun; 1050():274-85. PubMed ID: 16014543
[TBL] [Abstract][Full Text] [Related]
10. An antineuronal autoantibody in paraneoplastic opsoclonus.
Budde-Steffen C; Anderson NE; Rosenblum MK; Graus F; Ford D; Synek BJ; Wray SH; Posner JB
Ann Neurol; 1988 May; 23(5):528-31. PubMed ID: 3389761
[TBL] [Abstract][Full Text] [Related]
11. Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia.
Pranzatelli MR; Tate ED; Wheeler A; Bass N; Gold AP; Griebel ML; Gumbinas M; Heydemann PT; Holt PJ; Jacob P; Kotagal S; Minarcik CJ; Schub HS
Pediatr Neurol; 2002 Nov; 27(5):384-7. PubMed ID: 12504207
[TBL] [Abstract][Full Text] [Related]
12. Antineuronal Nuclear Autoantibody Type 1/Anti-Hu-Associated Opsoclonus Myoclonus and Epilepsia Partialis Continua: Case Report and Literature Review.
Sweeney M; Sweney M; Soldán MM; Clardy SL
Pediatr Neurol; 2016 Dec; 65():86-89. PubMed ID: 27707529
[TBL] [Abstract][Full Text] [Related]
13. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome.
Blaes F; Fühlhuber V; Korfei M; Tschernatsch M; Behnisch W; Rostasy K; Hero B; Kaps M; Preissner KT
Ann Neurol; 2005 Aug; 58(2):313-7. PubMed ID: 15988749
[TBL] [Abstract][Full Text] [Related]
14. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.
Luque FA; Furneaux HM; Ferziger R; Rosenblum MK; Wray SH; Schold SC; Glantz MJ; Jaeckle KA; Biran H; Lesser M
Ann Neurol; 1991 Mar; 29(3):241-51. PubMed ID: 2042940
[TBL] [Abstract][Full Text] [Related]
15. Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal tumors.
Darnell RB; Furneaux HM; Posner JB
J Neurosci; 1991 May; 11(5):1224-30. PubMed ID: 1851215
[TBL] [Abstract][Full Text] [Related]
16. Sensory neuronopathy and small cell lung cancer: antineuronal antibody reacting with neuroblastoma cells.
Lövblad KO; Boucraut J; Bourdenet S; Burger D; Bernard D; Regli F; Steck AJ
J Neurol; 1993 Jun; 240(6):327-32. PubMed ID: 8393093
[TBL] [Abstract][Full Text] [Related]
17. Antineuronal antibodies in patients with neuroblastoma: relationships with clinical features.
Salmaggi A; Luksch R; Forno MG; Pozzi A; Silvani A; Boiardi A; Gasparini M; Nemni R
Tumori; 1997; 83(6):953-7. PubMed ID: 9526591
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus-myoclonus.
Pranzatelli MR; Travelstead AL; Tate ED; Allison TJ; Lee ND; Fisher J; Jasty R
J Pediatr Hematol Oncol; 2004 Nov; 26(11):718-23. PubMed ID: 15543005
[TBL] [Abstract][Full Text] [Related]
19. Multiplex serology of paraneoplastic antineuronal antibodies.
Maat P; Brouwer E; Hulsenboom E; VanDuijn M; Schreurs MW; Hooijkaas H; Smitt PA
J Immunol Methods; 2013 May; 391(1-2):125-32. PubMed ID: 23500780
[TBL] [Abstract][Full Text] [Related]
20. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
Dalmau J; Porta-Etessam J
Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
